T1D Fund Joins Financing Syndicate Proceeds to Fund Remainder of Phase 2a ‘ZONE’ Trial and Nonclinical Development of a Once-Weekly Version of ZT-01 TORONTO, ON – Zucara Therapeutics Inc., (“Zucara”… Read More
GlycoCage technology developed by GlycoNet researchers aims to improve current treatments for inflammatory bowel disease. A new approach to drug design can deliver medicine directly to the gut in mice… Read More
UBC Faculty of Medicine researchers have received new funding from the Government of British Columbia, in partnership with Genome BC and Genome Alberta, to accelerate the future of patient care and… Read More
The Biologics Manufacturing Centre (BMC) will be exhibiting at CPHI Americas 2025, a major event for the life sciences industry, taking place in Philadelphia from May 20 to 22, 2025. Visit us at Booth… Read More
The Biologics Manufacturing Centre (BMC) will participate in the Bloom Burton & Co. Healthcare Investor Conference, taking place on May 5–6, 2025, at the Metro Toronto Convention Centre. This premier event brings together Canadian, U.S.,… Read More
